Prediction of treatment response to 72 weeks of pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C after liver transplantation.

被引：0
|
作者：
Neumann, Ulf P. [1 ]
Schmeding, Maximilian [1 ]
Bahra, Marcus [1 ]
Neuhaus, Ruth [1 ]
Bergk, A. [1 ]
Berg, Thomas [1 ]
Neuhaus, Peter [1 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
570
引用
下载
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [21] Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
    Bronowicki, Jean-Pierre
    Ouzan, Denis
    Asselah, Tarik
    Desmorat, Herve
    Zarski, Jean-Pierre
    Foucher, Juliette
    Bourliere, Marc
    Renou, Christophe
    Tran, Albert
    Melin, Pascal
    Hezode, Christophe
    Chevalier, Michelle
    Bouvier-Alias, Magali
    Chevaliez, Stephane
    Montestruc, Francois
    Lonjon-Domanec, Isabelle
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2006, 131 (04) : 1040 - 1048
  • [22] Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C
    van Leusen, Robert
    Adang, Rob P. R.
    de Vries, Richard A.
    Cnossen, Trijntje T.
    Konings, Constantijn J. A. M.
    Schalm, Solko W.
    Tan, Adriaan C. I. T. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 721 - 725
  • [23] Association of Host Pharmacodynamic Effects with Virologic Response to Pegylated Interferon alfa-2a/Ribavirin in Chronic Hepatitis C
    Chung, Raymond T.
    Poordad, Fred F.
    Hassanein, Tarek
    Zhou, Xiaolei
    Lentz, Ellen
    Prabhakar, Avinash
    Di Bisceglie, Adrian M.
    HEPATOLOGY, 2010, 52 (06) : 1906 - 1914
  • [24] Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2B plus ribavirin. Preliminary analysis
    Ghalib, RH
    Levine, CD
    Stribling, R
    McClelland, T
    Box, TD
    Hutson, WR
    Post, AB
    Regenstein, FG
    Zubi, A
    Seu, P
    Goss, J
    GASTROENTEROLOGY, 2003, 124 (04) : A694 - A694
  • [25] PEGYLATED INTERFERON ALFA-2A VS PEGYLATED INTERFERON ALFA-2B, PLUS RIBAVIRIN, FOR CHRONIC HEPATITIS C GENOTYPE 4 PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Kamal, Sanaa
    Ghoraba, Dalia
    Nabegh, Leila
    Nasser, Imad
    Motaoe, Mona
    Sayed, Mohamed E.
    Gohary, Iman
    HEPATOLOGY, 2009, 50 (04) : 1025A - 1026A
  • [26] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [27] INCIDENCE AND PREDICTORS OF HEMATOLOGICAL ABNORMALITIES DURING COMBINATION TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON ALFA-2A OR ALFA-2B PLUS RIBAVIRIN
    Nachnani, Anil
    Clarkston, Wendell K.
    Alba, Laura M.
    HEPATOLOGY, 2008, 48 (04) : 896A - 896A
  • [28] Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
    Kanda, T.
    Yokosuka, O.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2011, 50 (01) : 41 - 48
  • [29] Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice
    Lee, SS
    Bain, VG
    Peltekian, K
    Krajden, M
    Yoshida, EM
    Deschenes, M
    Heathcote, J
    Bailey, RJ
    Simonyi, S
    Sherman, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 397 - 408
  • [30] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2A OF CHRONIC HEPATITIS B IN CHILDREN
    Pawlowska, Malgorzata
    Halota, Waldemar
    HEPATOLOGY, 2009, 50 (04) : 633A - 634A
12345